MX9705829A - Medio de contraste para formacion de imagenes in vivo a base de transmision o reflexion de luz. - Google Patents

Medio de contraste para formacion de imagenes in vivo a base de transmision o reflexion de luz.

Info

Publication number
MX9705829A
MX9705829A MX9705829A MX9705829A MX9705829A MX 9705829 A MX9705829 A MX 9705829A MX 9705829 A MX9705829 A MX 9705829A MX 9705829 A MX9705829 A MX 9705829A MX 9705829 A MX9705829 A MX 9705829A
Authority
MX
Mexico
Prior art keywords
reflection
light transmission
vivo imaging
contrast media
imaging based
Prior art date
Application number
MX9705829A
Other languages
English (en)
Other versions
MXPA97005829A (es
Inventor
Jo Klaveness
Bjorn Fuglaas
Pal Rongved
Edvin Johannesen
Paul Mark Henrichs
Wolfgang Hans Heinrich Gunther
Edward Richard Bacon
John Luke Toner
Gregory Lynn Mcintire
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of MX9705829A publication Critical patent/MX9705829A/es
Publication of MXPA97005829A publication Critical patent/MXPA97005829A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0015—Phosphorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • A61K49/0091—Microparticle, microcapsule, microbubble, microsphere, microbead, i.e. having a size or diameter higher or equal to 1 micrometer
    • A61K49/0093—Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0476—Particles, beads, capsules, spheres
    • A61K49/0485—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/227—Liposomes, lipoprotein vesicles, e.g. LDL or HDL lipoproteins, micelles, e.g. phospholipidic or polymeric

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Acoustics & Sound (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se relaciona con el uso de materiales particulados como agentes de contraste en formacion de imágenes de luz in vivo.
MXPA/A/1997/005829A 1995-02-02 1997-07-31 Medio de contraste para formacion de imagenes in vivo a base de transmision o reflexion de luz MXPA97005829A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9502065.7 1995-02-02
GBGB9502065.7A GB9502065D0 (en) 1995-02-02 1995-02-02 Contrast media
PCT/GB1996/000222 WO1996023524A1 (en) 1995-02-02 1996-02-02 Contrast media for in vivo imaging based on light transmission on reflection

Publications (2)

Publication Number Publication Date
MX9705829A true MX9705829A (es) 1997-11-29
MXPA97005829A MXPA97005829A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
ES2182960T3 (es) 2003-03-16
JP4155596B2 (ja) 2008-09-24
FI973208A (fi) 1997-10-01
FI973208A0 (fi) 1997-08-01
NO973542D0 (no) 1997-08-01
JPH10513175A (ja) 1998-12-15
AU4545896A (en) 1996-08-21
GB9502065D0 (en) 1995-03-22
NO973542L (no) 1997-10-01
EP0808175A1 (en) 1997-11-26
KR19987001880A (es) 1998-06-25
EP0808175B1 (en) 2002-07-31
WO1996023524A1 (en) 1996-08-08
DE69622693D1 (de) 2002-09-05
CA2212257A1 (en) 1996-08-08
KR19980701880A (ko) 1998-06-25
HUP9900610A2 (hu) 1999-07-28
BR9607012A (pt) 1997-10-28
DE69622693T2 (de) 2003-04-03

Similar Documents

Publication Publication Date Title
NO973542L (no) Kontrastmedier for in vivo billeddannelse basert på lystransmisjon ved refleksjon
AU7221698A (en) Light imaging contrast agents
AU1818695A (en) Gas-containing microcapsules useful as contrast agents for diagnostic imaging
AU3677595A (en) Laser imaging system using self-detection for confocality
AU6867696A (en) Non-receptor mediated imaging agents
AU2276495A (en) Contrast agents for diagnostic imaging
AU3462495A (en) Light source cooler for lcd monitor
AU8579498A (en) Methods for improving the accuracy in differential diagnosis on radiologic examinations
AU5375696A (en) Inspection of optical components
DE69614162D1 (de) Dispersionskompensierung in optischen Übertragungssystemen
IL115479A (en) Composition comprising diclofenac potassium for ophthalmic use
AU5510196A (en) Ultrasonic inspection
AU6675798A (en) Light source cooler for lcd monitor
ZA963997B (en) Lubricants with molybdenum containing compositions and methods of using the same.
GB2326760B (en) Optical source with monitor
DE69609086D1 (de) Kompensation der wellenlängendispersionssteigung in optischen übertragungssystemen
AU2377497A (en) Proteins involved in the synthesis and assembly of o-antigen in (pseudomonas aeruginosa)
HU9602337D0 (en) Fibrin-specific antibody for use as an antithrombotic agent
FR2764086B1 (fr) Perfectionnement au systeme d'eclairage arriere pour modulateur electro-optique transmissif
GB2334318B (en) Pipeline vehicle & probe
AU6806094A (en) Pocket-size device, with microscopic magnifying and incorporated light source for the visualization, through the saliva, of the female fertility
ZA972627B (en) Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media.
AU7390891A (en) Anti-oncostatin m monoclonal antibodies
AU3116395A (en) Contrast mediums for use in imaging the liver
AU5157396A (en) Antibody to the syncytiotrophoblast antigen r80k and use the reof